Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Rainer Malik¹, Marios K Georgakis¹, Marijana Vujkovic^{2

3}, Scott M Damrauer^{2

3}, Paul Elliott^{4

5

6

7

8

9}, Ville Karhunen⁴, Alice Giontella^{10

11}, Cristiano Fava^{10

11}, Jacklyn N Hellwege¹², Megan M Shuey¹², Todd L Edwards¹³, Tormod Rogne^{14

15

16}, Bjørn O Åsvold^{17

18}, Ben M Brumpton^{19

18}, Stephen Burgess^{20

21}, Martin Dichgans^{1

22

23}, Dipender Gill^{4

5

24

25

26}

Affiliations

¹ Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany (R.M., M.K.G., M.D.).
² Perelman School of Medicine, University of Pennsylvania, Philadelphia (M.V., S.M.D.).
³ Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA (M.V., S.M.D.).
⁴ Department of Epidemiology and Biostatistics, School of Public Health (P.E., V.K., D.G.), Imperial College London, United Kingdom.
⁵ British Heart Foundation Centre of Research Excellence (P.E., D.G.), Imperial College London, United Kingdom.
⁶ School of Public Health, Medical Research Council-Public Health England Centre for Environment (P.E.).
⁷ UK Dementia Research Institute at Imperial College London, United Kingdom (P.E.).
⁸ Imperial Biomedical Research Centre, Imperial College London and Imperial College NHS Healthcare Trust, United Kingdom (P.E.).
⁹ Health Data Research UK London (P.E.).
¹⁰ Department of Medicine, University of Verona, Italy (A.G., C.F.).
¹¹ Department of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden (A.G., C.F.).
¹² Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt Epidemiology Center (J.N.H., M.M.S.) Vanderbilt University Medical Center, Nashville, TN.
¹³ Division of Epidemiology, Department of Medicine, Vanderbilt Genetics Institute (T.L.E.), Vanderbilt University Medical Center, Nashville, TN.
¹⁴ Department of Circulation and Medical Imaging, Gemini Center for Sepsis Research, Norwegian University of Science and Technology, Trondheim, Norway (T.R.).
¹⁵ Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT (T.R.).
¹⁶ Clinic of Anaesthesia and Intensive Care (T.R.), St. Olav's Hospital, Trondheim University Hospital, Norway.
¹⁷ Department of Endocrinology, Clinic of Medicine (B.O.Å.), St. Olav's Hospital, Trondheim University Hospital, Norway.
¹⁸ Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology (B.O.Å., B.M.B.).
¹⁹ Clinic of Thoracic and Occupational Medicine (B.M.B.), St. Olav's Hospital, Trondheim University Hospital, Norway.
²⁰ Cardiovascular Epidemiology Unit, University of Cambridge, United Kingdom (S.B.).
²¹ Medical Research Council Biostatistics Unit, University of Cambridge, United Kingdom (S.B.).
²² Munich Cluster for Systems Neurology, Germany (M.D.).
²³ German Centre for Neurodegenerative Diseases, Munich, Germany (M.D.).
²⁴ Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London, United Kingdom (D.G.).
²⁵ Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George's University Hospitals NHS Foundation Trust, London, United Kingdom (D.G.).
²⁶ Novo Nordisk Research Centre Oxford, Old Road Campus, United Kingdom (D.G.).

PMID: 33813844
PMCID: PMC8115430
DOI: 10.1161/HYPERTENSIONAHA.120.16534

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Rainer Malik et al. Hypertension. 2021 Jun.

. 2021 Jun;77(6):2004-2013.

doi: 10.1161/HYPERTENSIONAHA.120.16534. Epub 2021 Apr 5.

Authors

Affiliations

¹ Institute for Stroke and Dementia Research, University Hospital, Ludwig-Maximilians-University LMU, Munich, Germany (R.M., M.K.G., M.D.).
² Perelman School of Medicine, University of Pennsylvania, Philadelphia (M.V., S.M.D.).
³ Corporal Michael Crescenz Veterans Affairs Medical Center, Philadelphia, PA (M.V., S.M.D.).
⁴ Department of Epidemiology and Biostatistics, School of Public Health (P.E., V.K., D.G.), Imperial College London, United Kingdom.
⁵ British Heart Foundation Centre of Research Excellence (P.E., D.G.), Imperial College London, United Kingdom.
⁶ School of Public Health, Medical Research Council-Public Health England Centre for Environment (P.E.).
⁷ UK Dementia Research Institute at Imperial College London, United Kingdom (P.E.).
⁸ Imperial Biomedical Research Centre, Imperial College London and Imperial College NHS Healthcare Trust, United Kingdom (P.E.).
⁹ Health Data Research UK London (P.E.).
¹⁰ Department of Medicine, University of Verona, Italy (A.G., C.F.).
¹¹ Department of Clinical Sciences, Clinical Research Centre, Lund University, Malmö, Sweden (A.G., C.F.).
¹² Division of Genetic Medicine, Department of Medicine, Vanderbilt Genetics Institute, Vanderbilt Epidemiology Center (J.N.H., M.M.S.) Vanderbilt University Medical Center, Nashville, TN.
¹³ Division of Epidemiology, Department of Medicine, Vanderbilt Genetics Institute (T.L.E.), Vanderbilt University Medical Center, Nashville, TN.
¹⁴ Department of Circulation and Medical Imaging, Gemini Center for Sepsis Research, Norwegian University of Science and Technology, Trondheim, Norway (T.R.).
¹⁵ Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, CT (T.R.).
¹⁶ Clinic of Anaesthesia and Intensive Care (T.R.), St. Olav's Hospital, Trondheim University Hospital, Norway.
¹⁷ Department of Endocrinology, Clinic of Medicine (B.O.Å.), St. Olav's Hospital, Trondheim University Hospital, Norway.
¹⁸ Department of Public Health and Nursing, K.G. Jebsen Center for Genetic Epidemiology, Norwegian University of Science and Technology (B.O.Å., B.M.B.).
¹⁹ Clinic of Thoracic and Occupational Medicine (B.M.B.), St. Olav's Hospital, Trondheim University Hospital, Norway.
²⁰ Cardiovascular Epidemiology Unit, University of Cambridge, United Kingdom (S.B.).
²¹ Medical Research Council Biostatistics Unit, University of Cambridge, United Kingdom (S.B.).
²² Munich Cluster for Systems Neurology, Germany (M.D.).
²³ German Centre for Neurodegenerative Diseases, Munich, Germany (M.D.).
²⁴ Clinical Pharmacology and Therapeutics Section, Institute of Medical and Biomedical Education and Institute for Infection and Immunity, St George's, University of London, United Kingdom (D.G.).
²⁵ Clinical Pharmacology Group, Pharmacy and Medicines Directorate, St George's University Hospitals NHS Foundation Trust, London, United Kingdom (D.G.).
²⁶ Novo Nordisk Research Centre Oxford, Old Road Campus, United Kingdom (D.G.).

PMID: 33813844
PMCID: PMC8115430
DOI: 10.1161/HYPERTENSIONAHA.120.16534

Abstract

[Figure: see text].

Keywords: blood pressure; coronary artery disease; hypertension; primary prevention; stroke.

PubMed Disclaimer

Figures

**Figure 1.**
**Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes.** Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes: (A) all incident cardiovascular disease (CVD) events, (B) incident coronary artery disease (CAD), and (C) incident stroke. Displayed on the x axis are SBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a population mean SBP value of 136.5 mm Hg. Gray lines depict the 95% CI. Fractional polynomial test is a goodness-of-fit test assessing whether any improvement of fit using a nonlinear function to model the data compared with a linear function is greater than expected due to chance alone.

**Figure 2.**
**Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes.** Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes: (A) all incident cardiovascular disease (CVD) events, (B) incident coronary artery disease (CAD), and (C) incident stroke. Displayed on the x axis are DBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a population mean DBP value of 81.8 mm Hg. Gray lines depict the 95% CI.

**Figure 3.**
**Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes split by sex.** Nonlinear Mendelian randomization considering genetically proxied systolic blood pressure (SBP) and incident cardiovascular outcomes split by sex: (A) all incident cardiovascular disease (CVD) events in men, (B) incident coronary artery disease (CAD) in males, and (C) incident stroke in men. **D–F**, Equivalent analyses in women. Displayed on the x axis are SBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a mean SBP value of 136.5 mm Hg. Gray lines depict the 95% CI.

**Figure 4.**
**Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes split by sex.** Nonlinear Mendelian randomization considering genetically proxied diastolic blood pressure (DBP) and incident cardiovascular outcomes split by sex: (A) all incident cardiovascular disease (CVD) events in men, (B) incident coronary artery disease (CAD) in men, and (C) incident stroke in men. **D–F**, Equivalent analyses in women. Displayed on the x axis are DBP values in mm Hg. The y axis shows the hazard ratio for the respective incident cardiovascular event. Reference is set to a mean DBP value of 81.8 mm Hg. Gray lines depict the 95% CI.

See this image and copyright information in PMC

References

1. NCD Risk Factor Collaboration. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19.1 million participants. Lancet. 2017;389:37–55. doi: 10.1016/S0140-6736(16)31919-5 - PMC - PubMed
1. Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, et al. . Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395:795–808. doi: 10.1016/S0140-6736(19)32008-2 - PMC - PubMed
1. Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, Chalmers J, Rodgers A, Rahimi K. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387:957–967. doi: 10.1016/S0140-6736(15)01225-8 - PubMed
1. Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, Himmelfarb CD, Khera A, Lloyd-Jones D, McEvoy JW, et al. . 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140:e563–e595. doi: 10.1161/CIR.0000000000000677 - PMC - PubMed
1. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, et al. ; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37:2315–2381. doi: 10.1093/eurheartj/ehw106 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Affiliations

Relationship Between Blood Pressure and Incident Cardiovascular Disease: Linear and Nonlinear Mendelian Randomization Analyses

Authors

Affiliations

Abstract

Figures

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources